Education
About Us
Working with TipRanks
Follow Us
FINDEX Inc. (JP:3649)
:3649
3649 Stock Chart & Stats
¥824.00
-¥8.00(-0.93%)
At close: 4:00 PM EST
¥824.00
-¥8.00(-0.93%)
Day’s Range― - ―
52-Week Range¥598.00 - ¥1,011.00
Previous CloseN/A
Volume39.10K
Average Volume (3M)66.40K
Market Cap
¥21.54B
Enterprise Value¥18.70B
Total Cash (Recent Filing)¥2.38B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)16.8
Beta0.69
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.75%
Share Statistics
EPS (TTM)16.35
Shares Outstanding26,608,800
10 Day Avg. Volume40,110
30 Day Avg. Volume66,396
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)4.19
Price to Sales (P/S)3.73
P/FCF Ratio14.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High And Durable Profitability MarginsSustained high gross, operating, and net margins indicate strong pricing power and cost structure in FINDEX's healthcare information business. These margins create durable cash flow buffers against demand swings, support reinvestment in product development, and improve return on invested capital over multi-year horizons.
Exceptionally Conservative, Near-zero Debt Balance SheetNear-zero debt and growing equity provide significant financial flexibility, lowering refinancing and solvency risk. This capital structure allows FINDEX to fund organic growth, pursue selective M&A, sustain dividends, and withstand sector cyclicality without relying on external financing for 2–6+ months strategic moves.
Strong Cash Generation Aligned With EarningsFree cash flow tracking net income demonstrates earnings quality and convertibility to cash, enabling durable funding for capex, R&D, and shareholder returns. Over multiple years this alignment supports sustainable operations and lowers dependency on external capital for strategic investments.
Bears Say
Volatile Free Cash Flow Across The CycleIrregular free cash flow undermines predictability for reinvestment and stable dividends. Large swings reduce confidence in multi-year cash planning, make capex and hiring cadence harder to sustain, and elevate execution risk when management must smooth operations through downturns or seize growth opportunities.
Inconsistent Revenue Growth / Uneven DemandIntermittent top-line weakness and a past contraction indicate demand variability for FINDEX's services. Inconsistent revenue complicates long-term capacity planning, weakens visibility for multi-year investments, and may limit consistent scale benefits despite strong margins during growth years.
Equity Dip In 2024 Raises Modest Solvency WatchA decline in equity, even if recovered, suggests episodic pressure (earnings, reserves, or capital actions) that warrants monitoring. Recurrent equity erosion would weaken capital cushions and optionality; the 2024 dip is a structural indicator to track alongside cash flow and profit stability.
FINDEX Inc. News
3649 FAQ
What was FINDEX Inc.’s price range in the past 12 months?
FINDEX Inc. lowest stock price was ¥598.00 and its highest was ¥1011.00 in the past 12 months.
What is FINDEX Inc.’s market cap?
FINDEX Inc.’s market cap is ¥21.54B.
When is FINDEX Inc.’s upcoming earnings report date?
FINDEX Inc.’s upcoming earnings report date is May 20, 2026 which is in 90 days.
How were FINDEX Inc.’s earnings last quarter?
FINDEX Inc. released its earnings results on Feb 12, 2026. The company reported ¥16.35 earnings per share for the quarter, beating the consensus estimate of N/A by ¥16.35.
Is FINDEX Inc. overvalued?
According to Wall Street analysts FINDEX Inc.’s price is currently Overvalued.
Does FINDEX Inc. pay dividends?
FINDEX Inc. pays a Semiannually dividend of ¥9 which represents an annual dividend yield of 1.75%. See more information on FINDEX Inc. dividends here
What is FINDEX Inc.’s EPS estimate?
FINDEX Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FINDEX Inc. have?
FINDEX Inc. has 26,608,800 shares outstanding.
What happened to FINDEX Inc.’s price movement after its last earnings report?
FINDEX Inc. reported an EPS of ¥16.35 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.432%.
Which hedge fund is a major shareholder of FINDEX Inc.?
Currently, no hedge funds are holding shares in JP:3649
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FINDEX Inc.
FINDEX Inc. (3649) is a leading Japanese company specializing in the development and provision of medical information systems. The company focuses on creating software solutions that enhance healthcare operations, including electronic medical records (EMR), medical imaging systems, and other healthcare IT infrastructure. FINDEX Inc. aims to improve efficiency and accuracy within medical facilities by integrating advanced technology with healthcare services.
Technical Analysis
Options Prices
Currently, No data available
---